Keith Westby
Chief Operating Officer at IVERIC BIO, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glenn Sblendorio | M | 68 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 15 years |
| Mark Reisenauer | M | 58 | 1 years | |
| Kathy Galante | F | - | 11 years | |
| Evelyn Harrison | F | - | 17 years | |
| Dhaval Desai | M | - | 4 years | |
| Amy Sheehan | F | - | 10 years | |
| Xiao Ping Dai | M | - | - | |
| Christopher Simms | M | 49 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Guyer | M | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 20 years |
| Adrienne Graves | M | 69 | 5 years | |
| Pravin Dugel | M | 60 | 3 years | |
| Axel Bolte | M | 52 | 16 years | |
| Thomas Dyrberg | M | 69 | 12 years | |
| Mark Blumenkranz | M | 73 | 3 years | |
| David E. Redlick | M | 73 | 3 years | |
| Calvin Roberts | M | 71 | 4 years | |
| Marty Glick | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
| Barbara Wood | F | 62 | 5 years | |
| Ian Smith | M | 58 | 1 years | |
| Jane Henderson | F | 58 | 5 years | |
| Kourous Rezaei | M | - | 5 years | |
| Christine Ann Miller | F | 48 | 1 years | |
| Paul Chaney | M | 66 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 10 years |
| Michael Ross | M | 75 | 6 years | |
| Daniel Salain | M | 57 | 2 years | |
| Christopher Carroll | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 1 years |
| Anthony Gibney | M | 53 | 2 years | |
| Guang Ping Gao | M | - | - | |
| Thomas Ciulla | M | 59 | 2 years | |
| Vishal Kapoor | M | 48 | 4 years | |
| Abraham Scaria | M | - | - | |
| William T. Symonds | M | 56 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 5 years |
| Loni da Silva | F | - |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 5 years |
| Jennifer Burstein | F | 52 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Patricia Snyder-Johnson | F | - |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 1 years |
| Jeffrey Nau | M | 49 | 4 years | |
| Barrett Katz | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Clare M. Carmichael | F | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| Henric Bjarke | M | 57 | 2 years | |
| Fredric D. Price | M | 78 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 3 years |
| Enrique Dilone | M | 57 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 4 years |
| Joseph T. Kennedy | M | 56 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 2 years |
| M. Berrey | M | 57 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 5 years |
| Snehal Shah | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 44 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Keith Westby
- Personal Network
